Article Text
Therapeutics
Review: verteporfin plus photodynamic therapy reduces loss of vision in age related macular degeneration
Statistics from Altmetric.com
Q In patients with neovascular age related macular degeneration (AMD), what is the effect of photodynamic therapy?
Clinical impact ratings GP/FP/Primary care ★★★★☆☆☆
METHODS
Data sources:
Cochrane Central Register of Controlled Trials, Medline, EMBASE/Excerpta Medica (to January 2003), Science Citation Index; reference lists; and contact with experts.
Study selection and assessment:
randomised controlled trials that compared photodynamic therapy with placebo, no treatment, or another treatment in people with neovascular AMD.
Outcome:
prevention of visual loss.
MAIN RESULTS
2 studies (948 participants) were included. Both studies compared verteporfin, 6 mg/m2 (intravenous infusion of 30 ml/10 min), plus …